Johnson & Johnson plans to start testing the company’s experimental Covid-19 vaccine in youths aged 12 to 18 as soon as possible, a company executive said at a meeting held by the U.S. Centers for Disease Control and Prevention (CDC).
Pharma Companies Strike Deals to Deliver Millions of Covid-19 Vaccines by 2021
"Operation Warp Speed" Initiative, AstraZeneca, Biomedical Advanced Research and Development Authority (BARDA), Business, Clinical Trials, COVID-19 Vaccines, Deals, GlaxoSmithKline, Immune Response, Johnson & Johnson, Manufacturing, Moderna, Novavax, Pfizer, Pharma Companies, R&D, SanofiLeading pharmaceutical companies – including Moderna, Pfizer and AstraZeneca – are racing ahead to develop and distribute a Covid-19 vaccine.